| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Xinyi Wang, Haiyun Wang, Zhenghui Ye, Guofei Ding, Fengli Li, Ji Ma, Wei Hu. The neurocognitive and BDNF changes of multicomponent exercise for community-dwelling older adults with mild cognitive impairment or dementia: a systematic review and meta-analysis. Aging. vol 12. issue 6. 2021-02-22. PMID:32191630. |
in conclusion, this meta-analysis indicated that group exercises improve cognition, attention and executive function in community-dwelling older adults with mild cognitive impairment or alzheimer's disease. |
2021-02-22 |
2023-08-13 |
Not clear |
| Hanna Chainay, Fanny Gauber. Affective and cognitive theory of mind in Alzheimer's disease: The role of executive functions. Journal of clinical and experimental neuropsychology. vol 42. issue 4. 2021-02-17. PMID:32063090. |
affective and cognitive theory of mind in alzheimer's disease: the role of executive functions. |
2021-02-17 |
2023-08-13 |
Not clear |
| Meral A Tubi, Franklin W Feingold, Deydeep Kothapalli, Evan T Hare, Kevin S King, Paul M Thompson, Meredith N Braski. White matter hyperintensities and their relationship to cognition: Effects of segmentation algorithm. NeuroImage. vol 206. 2020-12-28. PMID:31682983. |
in a sample of 260 non-demented participants (ages 55-90, 141 males, 119 females) from the alzheimer's disease neuroimaging initiative (adni), we compared the performance of five wmh segmentation methods, by relating the wmh volumes derived using each method to both clinical diagnosis and composite measures of executive function and memory. |
2020-12-28 |
2023-08-13 |
human |
| Kritleen K Bawa, Saffire H Krance, Nathan Herrmann, Hugo Cogo-Moreira, Michael Ouk, Di Yu, Che-Yuan Wu, Sandra E Black, Krista L Lanctôt, Walter Swardfage. A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer's disease. Journal of neuroinflammation. vol 17. issue 1. 2020-12-08. PMID:32171317. |
a peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild alzheimer's disease. |
2020-12-08 |
2023-08-13 |
Not clear |
| Susan W Hunter, Alison Divine, Edward Madou, Humberto Omana, Keith D Hill, Andrew M Johnson, Jeffrey D Holmes, Walter Wittic. Executive function as a mediating factor between visual acuity and postural stability in cognitively healthy adults and adults with Alzheimer's dementia. Archives of gerontology and geriatrics. vol 89. 2020-12-07. PMID:32388070. |
executive function as a mediating factor between visual acuity and postural stability in cognitively healthy adults and adults with alzheimer's dementia. |
2020-12-07 |
2023-08-13 |
Not clear |
| Yan-Li Wang, Wei Chen, Wen-Jie Cai, Hao Hu, Wei Xu, Zuo-Teng Wang, Xi-Peng Cao, Lan Tan, Jin-Tai Y. Associations of White Matter Hyperintensities with Cognitive Decline: A Longitudinal Study. Journal of Alzheimer's disease : JAD. vol 73. issue 2. 2020-11-18. PMID:31839612. |
cross-sectional and longitudinal associations of wmhs with 8 cognitive domains were explored, using mini-mental state examination (mmse), montreal cognitive assessment (moca), clinical dementia rating sum of boxes (cdrsb), alzheimer disease assessment scale-cognitive (adas-cog13), rey auditory verbal learning test (ravlt), functional assessment questionnaire (faq), executive function (adni-ef), and memory function (adni-mem). |
2020-11-18 |
2023-08-13 |
Not clear |
| Joël Macoir, Anne Lafay, Carol Hudo. The Impairment of Number Transcoding Abilities in Individuals with Amnestic Mild Cognitive Impairment and Alzheimer Disease: Associations With Attentional and Executive Functions. Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology. vol 33. issue 1. 2020-10-27. PMID:32132401. |
the impairment of number transcoding abilities in individuals with amnestic mild cognitive impairment and alzheimer disease: associations with attentional and executive functions. |
2020-10-27 |
2023-08-13 |
Not clear |
| Dubravka Švob Štrac, Nela Pivac, Dorotea Mück-Šele. The serotonergic system and cognitive function. Translational neuroscience. vol 7. issue 1. 2020-10-01. PMID:28123820. |
symptoms of cognitive dysfunction like memory loss, poor concentration, impaired learning and executive functions are characteristic features of both schizophrenia and alzheimer's disease (ad). |
2020-10-01 |
2023-08-13 |
human |
| Eri Nitta, Keiichi Onoda, Fuminori Ishitobi, Ryota Okazaki, Seiji Mishima, Atsushi Nagai, Shuhei Yamaguch. Enhanced Feedback-Related Negativity in Alzheimer's Disease. Frontiers in human neuroscience. vol 11. 2020-10-01. PMID:28503138. |
alzheimer's disease (ad), the most common cause of dementia in the elderly, results in the impairment of executive function, including that of performance monitoring. |
2020-10-01 |
2023-08-13 |
Not clear |
| Steven D Edland, M Colin Ard, Weiwei Li, Lingjing Jian. Design of pilot studies to inform the construction of composite outcome measures. Alzheimer's & dementia (New York, N. Y.). vol 3. issue 2. 2020-10-01. PMID:28920073. |
for example, the prodromal alzheimer's cognitive composite (pacc) is the sum of z-score normed component measures assessing episodic memory, timed executive function, and global cognition. |
2020-10-01 |
2023-08-13 |
Not clear |
| Mauricéa Tabósa Ferreira Santos, Gutemberg Guerra, Terce Liana de Menezes, Tatiana Lins Carvalho, João Carlos Alchieri, Everton Botelho Souge. Preliminary data on a mnemonic instrument with proverbs for tracking Alzheimer's disease. Dementia & neuropsychologia. vol 2. issue 4. 2020-10-01. PMID:29213595. |
in the differential diagnosis between alzheimer's disease (ad) and normal aging, tests evaluating memory and executive functions are frequently used. |
2020-10-01 |
2023-08-13 |
Not clear |
| David T Blake, Alvin V Terry, Marc Plagenhoef, Christos Constantinidis, Ruifeng Li. Potential for intermittent stimulation of nucleus basalis of Meynert to impact treatment of alzheimer's disease. Communicative & integrative biology. vol 10. issue 5-6. 2020-10-01. PMID:29260798. |
the brain's cholinergic arousal pathways decline in parallel with the brain's executive functions in aging and alzheimer's disease. |
2020-10-01 |
2023-08-13 |
monkey |
| Xiaoqin Hu, Chengwei Song, Ming Fang, Chengyan L. Simvastatin inhibits the apoptosis of hippocampal cells in a mouse model of Alzheimer's disease. Experimental and therapeutic medicine. vol 15. issue 2. 2020-10-01. PMID:29434767. |
alzheimer's disease is associated with cognitive impairments that affect memory and executive functions. |
2020-10-01 |
2023-08-13 |
mouse |
| Angela Guarino, Francesca Favieri, Ilaria Boncompagni, Francesca Agostini, Micaela Cantone, Maria Casagrand. Executive Functions in Alzheimer Disease: A Systematic Review. Frontiers in aging neuroscience. vol 10. 2020-10-01. PMID:30697157. |
executive functions in alzheimer disease: a systematic review. |
2020-10-01 |
2023-08-13 |
human |
| Angela Guarino, Francesca Favieri, Ilaria Boncompagni, Francesca Agostini, Micaela Cantone, Maria Casagrand. Executive Functions in Alzheimer Disease: A Systematic Review. Frontiers in aging neuroscience. vol 10. 2020-10-01. PMID:30697157. |
this study aims to analyse, through a systematic review of the studies, the sensitivity of four experimental paradigms (wisconsin card sorting test, stroop task, go/no-go task, and flanker task) considered as golden standard instruments for executive functions assessment in elderly subjects affected by alzheimer dementia. |
2020-10-01 |
2023-08-13 |
human |
| Sangsoon Kim, Yeonwook Kang, Kyung-Ho Yu, Byung-Chul Le. Disproportionate Decline of Executive Functions in Early Mild Cognitive Impairment, Late Mild Cognitive Impairment, and Mild Alzheimer's Disease. Dementia and neurocognitive disorders. vol 15. issue 4. 2020-10-01. PMID:30906359. |
disproportionate decline of executive functions in early mild cognitive impairment, late mild cognitive impairment, and mild alzheimer's disease. |
2020-10-01 |
2023-08-13 |
Not clear |
| Omar M Al-Janabi, Christopher E Bauer, Larry B Goldstein, Richard R Murphy, Ahmed A Bahrani, Charles D Smith, Donna M Wilcock, Brian T Gold, Gregory A Jich. White Matter Hyperintensity Regression: Comparison of Brain Atrophy and Cognitive Profiles with Progression and Stable Groups. Brain sciences. vol 9. issue 7. 2020-10-01. PMID:31330933. |
a sample of 351 participants from the alzheimer's disease neuroimaging initiative 2 (adni2) was explored who had wmh volumetric quantification, structural brain measures, and cognitive measures (memory and executive function) at baseline and after approximately 2 years. |
2020-10-01 |
2023-08-13 |
human |
| Chan Tiel, Felipe Kenji Sudo, Ana Beatriz Calmo. Neuropsychiatric symptoms and executive function impairments in Alzheimer's disease and vascular dementia: The role of subcortical circuits. Dementia & neuropsychologia. vol 13. issue 3. 2020-10-01. PMID:31555401. |
neuropsychiatric symptoms and executive function impairments in alzheimer's disease and vascular dementia: the role of subcortical circuits. |
2020-10-01 |
2023-08-13 |
Not clear |
| Drew W R Halliday, Jodie R Gawryluk, Mauricio A Garcia-Barrera, Stuart W S MacDonal. White Matter Integrity Is Associated With Intraindividual Variability in Neuropsychological Test Performance in Healthy Older Adults. Frontiers in human neuroscience. vol 13. 2020-09-30. PMID:31680907. |
in this study, dispersion was examined alongside composite scores of memory and executive functioning from the alzheimer's disease neuroimaging initiative (adni). |
2020-09-30 |
2023-08-13 |
Not clear |
| Norelle C Wildburger, Frank Gyngard, Christelle Guillermier, Bruce W Patterson, Donald Elbert, Kwasi G Mawuenyega, Theresa Schneider, Karen Green, Robyn Roth, Robert E Schmidt, Nigel J Cairns, Tammie L S Benzinger, Matthew L Steinhauser, Randall J Batema. Amyloid-β Plaques in Clinical Alzheimer's Disease Brain Incorporate Stable Isotope Tracer Frontiers in neurology. vol 9. 2020-09-29. PMID:29623063. |
amyloid-β plaques in clinical alzheimer's disease brain incorporate stable isotope tracer alzheimer's disease (ad) is a neurodegenerative disorder with clinical manifestations of progressive memory decline and loss of executive function and language. |
2020-09-29 |
2023-08-13 |
Not clear |